Author:
Korf Dirk,Benschop Annemieke,Werse Bernd,Kamphausen Gerrit,Felvinczi Katalin,Dąbrowska Katarzyna,Hernriques Susana,Nabben Ton,Wieczorek Łukasz,Bujalski Michał,Kalo Zsusza,Hearne Evelyn,Van Hout Marie Claire
Abstract
AbstractUse of new psychoactive substances (NPS) across Europe remains a public health challenge. The study describes potentials and limitations of methods in a transnational survey of recent marginalised, nightlife and online community NPS users in Germany, Hungary, Ireland, the Netherlands, Poland and Portugal (n = 3023). In terms of demographic profile, drug use history and type of NPS, different methods reached different segments of the NPS-using population. Last year use of different NPS varied across countries and groups. Respondents used NPS in a variety of settings, with public spaces most common in the marginalised group. The study suggests that prevalence rates can reveal a picture of the NPS market that significantly deviates from what law enforcement seizures indicate. Outreach in nightlife settings and peer education are recommended to inform users about health risks and to improve access to drug services and care.
Funder
European Commission, DG Justice
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference25 articles.
1. Carhart-Harris, R. L., King, L. A., & Nutt, D. (2011). A web-based survey on mephedrone. Drug and Alcohol Dependence, 11(1), 19–22.
2. Dabrowaska, K., & Bujalski, M. (2013). The legal highs problem in the Polish printed media—actors, claims and its hidden meanings. Substance Use & Misuse, 48(1–2), 31–40. https://doi.org/10.3109/10826084.2012.720336.
3. EMCDDA. (2014). European drug report 2014: trends and development. Lisbon: EMCDDA.
4. EMCDDA. (2016). New psychoactive substances in Europe: legislation and prosecution—current challenges and solutions. Lisbon: EMCDDA.
5. EMCDDA. (2017a). High-risk drug use and new psychoactive substances. In Results from an EMCDDA trendspotter study. Lisbon: EMCDDA.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献